Literature DB >> 14097389

FLUORINATED PYRIMIDINES. XX. INHIBITION OF THE NUCLEOSIDE PHOSPHORYLASE CLEAVAGE OF 5-FLUORO-2'-DEOXYURIDINE BY 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE.

C HEIDELBERGER, G D BIRNIE, J BOOHAR, D WENTLAND.   

Abstract

Entities:  

Keywords:  CARBON ISOTOPES; CARCINOMA, EHRLICH TUMOR; ENZYME INHIBITORS; EXPERIMENTAL LAB STUDY; FLUORINE; FLUORODEOXYURIDINE; GLUCOSYLTRANSFERASES; NUCLEOSIDES; TISSUE EXTRACTS

Mesh：

Substances：

Year:  1963        PMID： 14097389

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  6 in total

1.  Phosphorolysis of 5-fluoro-2'-deoxyuridine in Escherichia coli and its inhibition by nucleosides.

Authors:  E Yagil; A Rosner
Journal:  J Bacteriol       Date:  1971-11       Impact factor: 3.490

Review 2.  The fluoropyrimidines: biochemical mechanisms and design of clinical trials.

Authors:  M A Friedman; W Sadée
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

3.  Pharmacokinetics of 5-fluorouracil: inter-relationship with biochemical kinetics in monitoring therapy.

Authors:  W Sadee; C G Wong
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

4.  Synthesis of substituted 5-fluoro-5,6-dihydropyrimidines.

Authors:  D Cech; L Hein; R Wuttke; M von Janta-Lipinski; A Otto; P Langen
Journal:  Nucleic Acids Res       Date:  1975-11       Impact factor: 16.971

5.  Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenografts.

Authors:  Norihiko Suzuki; Fumio Nakagawa; Kazuaki Matsuoka; Teiji Takechi
Journal:  Oncol Rep       Date:  2016-10-27       Impact factor: 3.906

6.  Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancer.

Authors:  Norihiko Suzuki; Fumio Nakagawa; Teiji Takechi
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.